Stories written by

Sheena Cruickshank, The Conversation

T cell vaccines could be the key to long-term immunity against Covid-19

Many of the doses designed to date – including Moderna’s, Pfizer’s and AstraZeneca’s – have focused just on the spike protein of the coronavirus.

Sheena Cruickshank, The Conversation
· Jan 15, 2022 · 09:30 pm
Even if the effects of Covid-19 vaccines wane over time, they still save lives

In the UK and the US, fewer vaccinated people need hospitalisation and are developing severe symptoms from the Delta variant.

Sheena Cruickshank, The Conversation
· Sep 17, 2021 · 07:30 pm
Is a third dose of Covid-19 vaccines really needed to boost the immune response?

Several studies have investigated the durability of immunity to coronavirus, and their results are encouraging.

Sheena Cruickshank, The Conversation
· Jul 13, 2021 · 09:30 pm